Zomagen Biosciences

Technologiepark 94

9052 Gent

BE

Zomagen Biosciences

Foundation date

26/02/2020

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Zomagen is a therapeutic product discovery & development biotech company focussed on compounds targeting the innate immune system, eventually to treat diseases with chronic inflammatory involvement.

Upcoming events

Latest news

  • Mayne Pharma and Mithra announce FDA approval of HALOETTE®, a generic version of NUVARING®

    7 hours ago

  • S-Biomedic welcomes Pascal Yvon to lead its B2B commercial activities

    Tuesday August 2nd 2022

  • Celyad Oncology announces FDA lifts clinical hold of CYAD-101-002 Phase 1b trial

    Monday August 1st 2022

Jobs by Zomagen Biosciences